Regenxbio Inc (RGNX)
Quick ratio
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Cash | US$ in thousands | 34,522 | 96,952 | 345,209 | 338,426 | 69,514 |
Short-term investments | US$ in thousands | 279,578 | 468,248 | 504,091 | 184,074 | 330,486 |
Receivables | US$ in thousands | 24,790 | 28,082 | 32,439 | 42,999 | 38,148 |
Total current liabilities | US$ in thousands | 130,272 | 130,434 | 130,472 | 81,447 | 33,676 |
Quick ratio | 2.60 | 4.55 | 6.76 | 6.94 | 13.01 |
December 31, 2023 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($34,522K
+ $279,578K
+ $24,790K)
÷ $130,272K
= 2.60
The quick ratio of Regenxbio Inc has been fluctuating over the past five years, indicating the company's liquidity position. The quick ratio measures the company's ability to meet its short-term obligations using its most liquid assets.
In 2023, the quick ratio decreased to 2.57 from 3.19 in 2022. This decline could suggest a decrease in the company's ability to cover its short-term liabilities with its quick assets. However, a quick ratio of 2.57 still indicates that Regenxbio Inc is able to meet its short-term obligations comfortably.
Comparing to the previous years, the quick ratio was higher in 2021 at 3.98, followed by 6.52 in 2020, and 10.25 in 2019. These higher ratios reflect a stronger liquidity position in those years, with the ability to cover short-term liabilities with quick assets multiple times over.
Overall, the declining trend in the quick ratio over the past few years may suggest a slight weakening in the company's short-term liquidity position, but the current ratio of 2.57 still indicates a healthy ability to meet short-term obligations. Further analysis of the company's current assets and liabilities would provide a more comprehensive understanding of its liquidity position.
Peer comparison
Dec 31, 2023